Claire Mazumdar, Chief Executive Officer at Bicara Therapeutics Inc. (BCAX), sold 48,206 shares at $18.83 ($908K) on 2025-10-16, disclosed to the SEC on 2025-10-20.
Scheduled sale ($908k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.83 | 24,103 | $454K | 50.0% |
| 2 | $18.83 | 24,103 | $454K | 50.0% |
| Total | $18.83 avg | 48,206 | $908K | 100% |
| Filing → |
| BCAX | SELL | 2026-05-20 | $301K | — | Filing → |
| BCAX | SELL | 2026-04-20 | $354K | — | Filing → |
| BCAX | SELL | 2026-03-20 | $565K | — | Filing → |